Bureaucratic procedures were an obstacle for other patients with cystic fibrosis to receive the Trikafta medication, in addition to the 12 patients who are already receiving it. This was announced at Monday’s meeting between the Minister of Health Fatmir Mexhiti and patients with this rare disease and their parents. There is no exact date when the new patients will start receiving the modulatory therapy, and the problem of the shortage of the drug Creon, which these people take daily with food, will be considered.
The president of the Cystic Fibrosis Association Fiki Gaspar said that the meeting discussed their request to have modular therapy for all patients.
